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Abstract
Recently, functional and potent RNA interference (RNAi) has been reported in peripheral nerve
axons transfected with short-interfering RNA (siRNA). In addition, components of RNA-induced
silencing complex (RISC) have been identified in axotomized sciatic nerve fibers as well as in
regenerating dorsal root ganglia (DRG) neurons in vitro. Based on these observations, and on the
fact that siRNA and microRNAs (miRNA) share the same effector enzymes, we hypothesized that
the endogenous miRNA biosynthetic pathway would respond to peripheral nerve injury. To
answer this question, we investigated changes in the expression of miRNA biosynthetic enzymes
following peripheral nerve crush injury in mice. Here we show that several pivotal miRNA
biosynthetic enzymes are expressed in an injury-regulated pattern in sciatic nerve in vivo, and in
DRG axons in vitro. Moreover, the sciatic nerve lesion induced expression of mRNA-processing
bodies (P-bodies), which are the local foci of mRNA degradation in DRG axons. In addition, a
group of injury-regulated miRNAs was identified by miRNA microarray and validated by qPCR
and in situ hybridization analyses. Taken together, our data support the hypothesis that the
peripheral nerve regeneration processes may be regulated by miRNA pathway.
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INTRODUCTION
One of the unique features of the peripheral nervous system (PNS) is its ability to regenerate
axons after injury (Yoo et al., 2009). To initiate a regenerative response, the PNS neuron
must shift its physiology from synaptic transmission and maintenance of structure to the
growth of the axon (Benowitz and Yin, 2007). Shifting to the growth phenotype requires
both activation of a growth program via gene transcription as well as activation of local
signaling cascades that regulate axon assembly (Snider et al., 2002, Vogelaar et al., 2009).
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Recent observations suggest that the microRNA (miRNA) pathway may be involved in
regulation of these processes (Hengst et al., 2006, Murashov et al., 2007).
The miRNA pathway is an important layer of post-transcriptional gene regulation (Jackson
et al., 2010). MiRNAs are initially processed in the nucleus by biosynthetic enzymes,
Drosha and DGCR8/Pasha, while in cytoplasm Dicer cleaves them into the mature miRNAs
(Bernstein et al., 2001, Lee et al., 2003). MiRNAs then trigger formation of RNA-induced
silencing complex (RISC), which is implicated in a sequence-specific translational
repression called RNA interference (RNAi) (Bagga et al., 2005, Tan et al., 2009). Several
subunits of RISC have been conclusively identified to date: Argonaute2 (Ago2) nuclease
(Hammond et al., 2001, Meister and Tuschl, 2004), fragile X mental retardation protein
(FMRP) (Ishizuka et al., 2002), p100 (Caudy et al., 2003), TRBP (Chendrimada et al.,
2005), PACT (Lee et al., 2006), and RCK/p54 (Chu and Rana, 2006). Recent studies
showed that Argonaute proteins interact with the RNA-binding protein GW182 (Sen and
Blau, 2005, Eulalio et al., 2009a, Eulalio et al., 2009b, Takimoto et al., 2009). Observations
revealed that GW182-containing foci, known as GW bodies (GWBs), coincide with mRNA-
processing bodies (P-bodies) where GW182 co-localizes with the de-capping complex
(Dcp1, Dcp2), Rap55 and Ro52 (Sen and Blau, 2005, Bhanji et al., 2007, Eulalio et al.,
2009a, Eulalio et al., 2009b, Takimoto et al., 2009). Importantly, depleting GW182
suppressed silencing of miRNA targets. Therefore, these observations suggest that in
addition to RISC, target silencing by miRNAs is regulated by P-bodies.
Recent studies revealed the differential expression of a number of miRNAs following
traumatic injury in CNS, including the brain and spinal cord (Lei et al., 2009). Reduction in
the expression of several sensory organ-specific miRNAs was also observed in the injured
ipsilateral dorsal root ganglion (DRG) following spinal nerve ligation (SNL) (Aldrich et al.,
2009). These evidences suggest that miRNAs are likely to be important mediators of
plasticity. Functional RNAi machinery has been reported in axons of PNS neurons (Yoo et
al., 2009). Components of RISC were observed in severed sciatic nerve fibers and cultured
DRG axons (Hengst et al., 2006, Murashov et al., 2007). Based on these observations and on
the fact that siRNA and miRNA share the same effector enzymes, it is logical to presume
that the endogenous miRNAs machinery could be involved in the regulation of molecular
response to peripheral nerve injury.
In the current study, we asked whether miRNA might be one of the pathways that respond to
peripheral nerve crush. Here we show an injury-regulated expression of several pivotal
miRNA biosynthetic enzymes in murine sciatic nerve in vivo, and in DRG axons in vitro. In
addition, a group of miRNAs, which were expressed in an injury-regulated pattern in
regenerating sciatic nerve and DRG was identified by miRNA microarrays, qPCR and in
situ hybridization. These data provide further evidence in support of the hypothesis that the
peripheral nerve regeneration processes may be regulated by miRNA pathway.
EXPERIMENTAL PROCEDURES
Animals
Experiments were performed on 8-wk-old CD-1 mice, obtained from Charles River
laboratories (Wilmington, MA). Animals were housed one per cage under standard
laboratory conditions, with a 12h light/dark schedule and unlimited access to food and
water. All experimental procedures and the care of the animals were administered according
to the guidelines set forth by the Animal Care and Use Committee of East Carolina
University, an AAALAC-accredited facility.
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Anesthesia was induced using intraperitoneal Ketamine (18/mg/ml)-Xylazine(2mg/ml)
mixture (0.05 ml/10g of body wt). The procedure followed a protocol described previously
(Islamov et al., 2004). Exposure of the right sciatic nerve was performed with sterile surgical
instruments. Approximately 5mm of nerve was exposed from the sciatic notch to the
trifurcation of the nerve. The exposed sciatic nerve was crushed in the mid-thigh for 15 sec
with a fine hemostat. The wounds were closed with 3M Vetbond tissue adhesive and mice
were allowed to recover for 4, 5 or 7 days. For the following experiment, the injured
ipsilateral nerves were called injured nerves and the ipsilateral DRGs were called injured
DRGs. The contralateral nerves were called naïve nerves and DRGs from contralateral side
were called naïve DRGs. Nerves and DRGs from intact animals were called intact nerves
and intact DRGs.
Sciatic nerve collection
After specified time periods, animals were euthanized and sciatic nerves were quickly
dissected out, snap frozen in liquid nitrogen and stored at −80°C. The naïve nerve was taken
from the contralateral side (sciatic nerve from left side). The excised crush sample was taken
from the injury side approximately 5 mm in both directions from the point of injury. The
intact nerve sample was taken from mice at the matched age without sciatic nerve crush
surgery.
Dissociated DRG culture
Mouse L4/5 dorsal root ganglion (DRG) neurons were collected 5 days after a conditioning
sciatic nerve crush from both the intact side and injured side. DRGs were dissociated with
collagenase and 0.25% trypsin in Dulbecco’s modified Eagle’s medium (DMEM). The
dissociated DRGs were plated on Poly-L-Lysine and Laminin (Invitrogen, Carlsbad, CA),
coated plates. DRGs were grown in DMEM/F12 containing 10% horse serum, L-glutamine
and N2 supplement at 37°C for 18hrs. Cytosin β-D-arabinofuranoside and 5,6-
dichlorobenzimidazole riboside (Sigma, Saint Louis, Missouri) were added to the final
concentration of 10μM and 80μM respectively in the growth medium to inhibit the growth
of glial cells.
Protein lysates
Proteins were extracted from the sciatic nerves collected at specific time points. To obtain
adequate proteins for these experiments, at least 5 animals were pooled per time-point.
Samples of sciatic nerves were homogenized in ice-cold homogenization buffer, containing
protease inhibitor cocktail (Sigma, St. Louis, MO), 1mM PMSF, 20mM Tris, 2mM EGTA,
2mM EDTA, 6mM β-mercaptoethanol and 10% Triton and centrifuged at 10,000g for 10
min at 4°C. The supernatant was transferred to a fresh tube and stored at −20 °C until ready
for use.
Immunoblotting
Proteins for Western Blotting analysis were quantified using the BioRad reagent, and 20 μg
of solubilized proteins were loaded per lane on sodium dodecyl sulfate gels and separated by
SDS-PAGE. The separated proteins were then transferred to immobilon P membranes
(Millipore Corporation; Bedford, MA). Membranes were blocked in 5% non-fat milk/PBST
for 1 hr at room temperature on a shaker, and then probed with primary antibody against
FMRP (Darnell et al., 2005), Ago2 (Ikeda et al., 2006), P-100 (Keenan et al., 2000), Dcp1
(Lykke-Andersen, 2002) or from Abnova; Walnut, CA, Dcp2 (Lykke-Andersen, 2002,
Wang et al., 2002), Rap55 (Yang et al., 2006), Ro52 and GWB IC-6 (Pauley et al., 2006) in
5% nonfat milk/PBST at 4°C overnight. For negative control groups, membranes were
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incubated with pre-immune serum. The membranes were washed three times with TBS, and
then incubated with secondary antibody in 5% milk/PBST for two hours at room
temperature. After incubation with horseradish peroxidase (HRP) conjugated secondary
antibodies, bound antibodies were detected using a chemiluminescence detection system
(ECL plus Western blotting detection reagent, Amersham; Arlington Heights, IL, USA).
Densitometry was performed using Kodak 1D Image Analysis software. Band values were
normalized to alpha-tubulin, to obtain the relative densitometric intensity. One-way
ANOVA were performed on injured, naive versus intact relative densitometric intensity for
each antibody tested.
List of antibodies
The following antibodies were used for immunodetection procedures: Rabbit polyclonal
anti-AGO2- specific antibody (kindly donated by Tom Hobman, University of Alberta,
Canada), Guinea pig polyclonal anti-P100 antibody (kindly donated by Tom Keenan, VA
Polytechinic Institute and State University, Blacksburg, VA). Mouse monoclonal anti-
FMRP antibody was purchased from Developmental Studies Hybridoma Bank(Iowa City,
Iowa). Western blot analysis of P-body components in the sciatic nerve utilized rabbit
polyclonal primary antibody against Dcp1, Dcp2 from Jens Lykke-Anderson (University of
Colorado, Colorado), rabbit polyclonal anti-Dcp2 primary antibody from M. Kilejian
(Rutgers University, New Jersey), Mouse Anti-Human Dcp1A Monoclonal Antibody from
Abnova (Walnut, CA), human anti-Rap55 antibody (from Donald Bloch, Harvard
University, MA) or antibody against GWB IC6 from Marvin Fritzler (University of Calgary,
Alberta, Canada), or Rabbit anti-Ro52 polyclonal antibody from Millipore Corporation
(Bedford, MA). Mouse monoclonal neuro-specific beta III tubulin antibody (TUJ-1) was
obtained from Covance Research Products, Inc. (Denver, PA). The specificities of the
antibodies, provided by individual investigators, have been validated by original research
groups and the corresponding papers have been published elsewhere. For secondary
antibodies, we used HRP conjugated anti-rabbit IgG and HRP conjugated anti-mouse IgG
from R&D system (Minneapolis, MN). IRDye 800CW goat anti-Mouse IgG and IRDye,
680LT goat anti-Rabbit IgG secondary antibodies were also used (LI-COR Corporate,
Nebraska USA). For fluorescence studies, secondary FITC-, TX Red-, Cy-3, or Cy5-
conjugated IgG (Jackson ImmunoResearch Laboratories, Inc; West Grove, PA) or Alexa
Fluor 350 (anti-mouse IgG) and Alexa Fluor 594 goat anti-human IgG from Invitrogen
(Eugene, Oregon, USA) were applied.
Indirect Immunofluorescence
After culturing lumbar DRGs on coverslips overnight, the DRGs were fixed with 4%
paraformaldehyde for 5 min and washed with PBST. After blocking with 10% goat serum
for 30 min at room temperature, the samples were incubated with the indicated primary
antibodies (1:100 dilution) at 4 °C overnight or for 2 hours at 37 °C. Bound antibodies were
detected using FITC-, TX Red-, AMCA- or Alexa Fluor® 594 (Invitrogen) conjugated IgG
in 1:100 dilutions. Negative controls included samples processed in parallel with non-
immune serum or without primary antibodies. After mounting the slides with anti-fading
media (Invitrogen), images were viewed with an Olympus IMT-2 fluorescent microscope
and recorded using the Spot digital camera system (Diagnostic Instruments, Sterling
Heights, MI) or viewed and captured with Leica DMI6000 B Imaging System powered by
MetaMorph. The images we acquired were all single plane fluorescent images. For high
magnification images and Z-stacks, images were taken with Olympus FluoView™ FV1000
confocal microscope at UNC Neuroscience Center (Chapel Hill, NC).
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Total RNA for the microarray expression analysis was isolated from sciatic nerves, pooled
from ten mice, at 4, and 7 days after the sciatic nerve crush. miRNA expression profiling.
Five micrograms of total RNA was labeled with RNA ligase and a Cy3-conjugated
dinucleotide, and hybridized to custom oligonucleotide microarrays as described previously
(Thomson et al., 2004). Cy3 median intensity values were filtered to remove data points that
did not exceed background levels by twofold (He et al., 2005). Values were log2-
transformed and median-centred by array. Clustering was performed with Cluster (Stanford
University), using values that were median-centred by gene. Dendrograms and expression
maps were generated using Treeview (Stanford). Some pooled samples were sent to UNC
Lineberger Comprehensive Cancer Center Genomics Core. Following a quality check, they
were hybridized to an 8×15K miRNA one color arrays (Agilent, Santa Clara, CA). Both
custom and Agilent arrays were done in duplicates and repeated two times. Normalization
and analyses were performed with GeneSpring software (Agilent). The GeneSpring analysis
software was used for the identification of statistically significant upregulated or
downregulated miRNAs at selected time points. The analysis also allowed for identification
of a different temporal pattern of expression in the crushed groups compared with the
control groups at the chosen time points. For further analyses we selected three miRNAs that
were significantly upregulated and one that was significantly downregulated in both custom
arrays as well as in Agilent arrays. The selected miRNAs were validated by qRT-PCR,
performed on the same total RNA preparations as used for microarrays experiments (Please
see supplementary data).
Real-time RT-PCR
Total RNA was isolated from intact and crushed sciatic nerves (n=6). Samples from the
experimental and control tissue were run two to three times in triplicates using the NCode™
miRNA Amplification System (Invitrogen) in a BioRad PCR thermocycler. Primers for
miRNA include miR124a (5′-TAAGGCACGCGGTGAATGCC-3′), miR221 (5′-
AGCTACATTGTCTGCTGGGTTTC-3′), U6 (Ambion mirVana™ qRT-PCR Primer Sets,
catalog #30303), miR142-5p (5′-CATAAAGTAGAAAGCACTACTAAAA-3′), miR-199a
(5′-ACAGTAGTCTGCACATTGGTTA-3′), miR9 (5′-
TCTTTGGTTATCTAGCTGTATGA-3′) and miR21 (5′-
TAGCTTATCAGACTGATGTTGA-3′). To ensure equal loading of RNA, relative
quantification of gene expression was calculated against reference gene S12. Data were
normalized to S12 using the 2−ΔΔCT method.
In situ hybridization
Similar to the immunofluorescence protocol described above, dissociated DRG cultures
were postfixed in 4% paraformaldehyde solution in PBS at room temperature for 5 min,
washed in PBS twice for 5 min and incubated in 100% methanol + 0.3% hydrogen peroxide
solution for 10 min at 4°C. After two washes in PBS for 10 min, cell cultures were
prehybridized at 42°C for 1 hour in hybridization buffer, containing 600 mM sodium
chloride, 50mM sodium phosphate buffer (PH 7.0), 5.0 mM EDTA, 0.02% Ficoll (Sigma),
0.02% BSA (Sigma), 0.02% polyvinylpyrrolidone (Sigma), 200ng/ml sheared and denatured
salmon sperm DNA (Sigma), and 40% formamide (Fisher Scientific, Pittsburgh, PA, USA).
Hybridization was performed at 42°C in the same buffer with the addition of dextran sulfate
to 7%, tRNA(baker’s yeast) to 0.1 mg/ml, poly-A to 10μg/ml, and LNA antisense or sense
oligonucleotide probes against miR-21, miR-142-5p and U6 to a final concentration of 1 ng/
μl. Mir-21 FITC –labeled LNA antisense and sense probes were obtained from RiboTask
(Odense, Denmark). Mir-142-5p FITC –labeled LNA antisense and scrambled probes, and a
U6 LNA probe were obtained from Exiqon (Woburn, MA). After hybridization coverslips
were incubated for 1 hour with primary antibodies against FITC, neuronal β-tubulin and
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GWB. To visualize the signal, FITC-, TX Red-, and AMCA- labeled secondary antibodies
(Invitrogen) were applied for 1 hour in 1:100 dilution. Slides were viewed on an Olympus
IMT-2 fluorescent microscope.
Statistical analysis
Statistical analysis was performed with one-way ANOVA and Newman-Keuls Multiple
Comparison Test using Prism (GraphPad Prism version 3.00 for Windows, GraphPad
Software; San Diego, CA, USA). All values are represented as the Mean ± SE.
RESULTS
Levels of miRNA biosynthetic proteins in sciatic nerve are regulated by injury
To investigate whether the expression of miRNA biosynthetic proteins was correlated with
injury, we first determined the expression of protein components of RISC (FMRP, Ago2 and
P-100) and P-body (Dcp1, Dcp2, Rap55, Ro52 and GWB IC-6) at 4 and 7 days post-crush.
In a mouse, the process of nerve regeneration has been shown to be active over this period,
justifying the time-points for these experiments (Garbay et al., 2000, McMurray et al.,
2003). Previous studies in our lab already showed the existence of the components of RISC
in peripheral nerve axon in vivo and vitro (Murashov et al., 2007). Here we used
immunoblot analyses to determine the injury-regulated expression of biosynthetic
components of RISC and P-body. Immunoblot analysis revealed the expression of the
components of these multiprotein complexes in response to injury, indicating the potential
role of miRNA biosynthetic machinery in peripheral nerve regeneration. Figure 1 indicates
that the expressions of the RISC components, including FMRP, Ago-2, and P-100 were
induced in response to injury, when compared to intact nerve. The densitometry showed
significantly elevated levels of Ago2, FMRP, and P-100 respectively at 4 days (Fig 1A) and
7 days (Fig 1B) after injury. The contralateral naïve side of the nerve had the comparable
expression level of RISC components as the intact nerve. The results indicated the induction
of RISC in sciatic nerve upon injury. In addition, the injury differentially affected levels of
P-body proteins, another miRNA-associated multiprotein complex (Figure 2). We observed
upregulation of Dcp1 and GWB IC-6 at 4 days following sciatic nerves injury (Fig 2A) and
downregulation of Dcp2 and Ro2 respectively, at 4 day post injury (Fig 2A). In contrast, the
expression of Rap55 was not affected. Therefore, the results indicated that injury to sciatic
nerve selectively affected the expression of the P-body components.
Components of miRNA machinery are differentially expressed in dissociated DRG neurons
after injury
In the previous experiments we showed that miRNA machinery was present and induced in
peripheral nerve after injury. In the next experiment we asked whether the source of the
differentially expressed miRNA biogenesis enzymes might be of axonal origin. To answer
this question, we performed immuofluorescence staining on murine dissociated DRG
neurons to visualize the presence of P-body proteins in axons. The DRG neurons plated at a
low density were stained with FITC conjugated antibodies against Dcp1 (Figure 3B) and
Alexa 594-conjugated antibodies against GWB IC-6 (Figure 3C). The human polyclonal
sera against GWB was used previously to detect P-bodies (Cougot et al., 2008). Since the
polyclonal antibodies could detect other proteins associated with GW182 protein in GWB
(Moser et al., 2007), antibodies against Dcp1, another major component in P-bodies was
used to further confirm the localization of P-bodies in axon. AMCA staining against TUJ1, a
neuronal marker indicated the location of neuronal soma and axons (Figure 3A). Confocal
immunofluorescence showed colocalization of GWB IC-6 with Dcp1 in the varicosities
(VR) along axons (Figure 3D). A Z-scanning showed a complete overlap of
immuoreactivities against Dcp1 and GWB in axon.
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These results clearly demonstrated the colocalization of P-bodies proteins in the VR along
axons. By comparing the images of DRG neurons collected from the injured side (Fig. 4A)
and the DRG neurons collected from the naïve side (Fig. 4B), we revealed that
preconditioning by crush injury not only induces more robust axon regenerative growth but
also induces P-bodies containing VR in regenerating axons. Quantifications of the mean
number of the VR containing P-bodies per neuron in naïve versus regenerating DRG
cultures, revealed that the average number of VR containing P-bodies per neuron increased
over ~2.4 fold, from around 3 (n=30) to around 8 (n=30) following injury (Fig. 4C). These
findings were consistent with the Western Blot results, which indicated that the expression
of miRNA biogenesis enzymes followed an injury-regulated pattern.
MiRNAs are expressed in an injury-regulated pattern after conditioning nerve lesion
Since we observed an injury-regulated expression of miRNA biosynthetic enzymes after the
sciatic nerve crush, we asked if the pattern of miRNA expression could be also injury-
regulated. Total RNA was isolated from pooled crushed and contralateral intact sciatic
nerves and subjected to custom (Thomson et al., 2004) and Agilent miRNA expression
arrays. Genespring analysis of array data revealed a set of differentially expressed miRNAs.
The miRNAs that were following injury-regulated expression pattern in both custom and
Agilent arrays at both 4 and 7 days time points were selected for subsequent analyses. Three
most highly upregulated miRNAs miR-21, miR-142-5p, and miR-221, as well as brain-
specific miR-124a, which was significantly downregulated, were selected for further
analyses (see Supplementary data).
qPCR confirms injury-regulated expression of miR-21, miR-142-5p, miR-221, and miR-124a
To verify miRNA array data, we next determined the expression of the selected miRNAs in
the same total RNA samples that were used for arrays. Real-Time RT-PCR demonstrated the
same pattern of expression of miR-124a, miR-221, miR-142-5p, and miR-21, after sciatic
nerve crush (Figure 5). In agreement with the microarray data, the real time RT-PCR
demonstrated that miR-124a is significantly downregulated after nerve injury. At the same
time, we observed an upregulation of miR-221, miR-142-5p, and miR-21. These data
provided further evidence that these miRNAs are injury-regulated.
In situ hybridization analysis localized injury-regulated miRNAs miR-21 and miR-142-5p to
regenerating DRG axons
In the previous experiments we have shown that several miRNAs are expressed in an injury-
regulated pattern in peripheral nerve. The potential sources of miRNAs in crushed nerve
samples could include, glial cells, connective tissue, macrophages and axons. In the next
experiment we asked whether the identified differentially expressed miRNAs might be
present in regenerating DRG neurons. To answer this question, we performed fluorescent in
situ hybridization (FISH) on murine dissociated DRG neurons plated at a low density to
visualize the presence of miRNAs in cell bodies and axons. For this experiment we selected
miR-21 and miR-142-5p, which showed an opposite regulation by injury in the miRNA
arrays. After FISH, DRG preparations were immunostained with TUJ1 antibody against
neuron-specific β-tubulin. The localization of P-bodies was visualized by immunostaining
against GWB IC-6. Analyses of these immunofluorescent images revealed presence of
miR-21 and miR-142-5p in DRG cells and their axons (Figure 5). Interestingly, the
distribution of miRNAs in the axon was overlapping with P-body immunostaining including
axon VR. These results demonstrate an interesting possibility that miRNAs could be induced
in cell body upon crush and subsequently translocated into the axon.
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Our study demonstrated that the levels of several miRNA biosynthetic proteins, as well as
miRNAs, were affected by sciatic nerve injury. This observation is supported by previous
studies, which demonstrated functional RNAi machinery in peripheral nerve axons
(Buckingham et al., 2004, Hengst et al., 2006, Murashov et al., 2007) and one recent
observation that has revealed expression of miRNAs in the superior cervical ganglia axons
(Natera-Naranjo et al., 2010). While these reports demonstrated that miRNAs and miRNA
biosynthetic enzymes are present in peripheral nerve axons in vivo and in vitro, there were
no systematic studies addressing physiological role of the miRNA biosynthetic pathway in
the PNS. In the current paper, we asked whether miRNA might be one of the pathways that
is activated in response of the PNS to peripheral nerve injury. To answer this question, we
investigated levels of miRNA biosynthetic proteins and miRNAs after nerve crush, as well
as their localization in regenerating cells and axons by FISH and indirect
immunofluorescence. Here we showed that several components of RISC and P-bodies, as
well as miRNAs were expressed in an injury-regulated pattern in the sciatic nerve and DRG
axons after crush injury, supporting a potential physiological role of miRNA pathway in
regulation of regenerative nerve growth.
Components of RISC and P-bodies respond to injury of peripheral nerve
In the previous observation we detected expression of several RISC components in murine
sciatic nerve (Murashov et al., 2007). In the current report, we observed increased protein
levels of Ago2, FMRP, and p100 in response to sciatic nerve crush. The observed injury-
regulated expression of these RISC components may indicate that the induction of RISC
may be a part of the PNS regenerative response. Interestingly, Ago2, the pivotal RISC
protein, was recently detected in P-bodies, as well as, in the stress granules (SGs), which
suggested a potential functional relationship between RISC, SGs and P-bodies in
physiological response to cellular stresses (Leung et al., 2006, Didiot et al., 2009). P-bodies
are an important component of the miRNA machinery as the sites for either degrading or
protecting and sequestering mRNA (Parker and Sheth, 2007, Balagopal and Parker, 2009).
P-bodies are dynamic complexes which assembly are dependent on, and proportional to, the
cytoplasmic pool of translationally repressed messenger ribonucleoproteins (mRNPs)
(Teixeira et al., 2005, Franks and Lykke-Andersen, 2008). Although the complete
composition of P-bodies is not yet established, they are known to include the decapping
enzymes Dcp1 and Dcp2, the activator of decapping Dhh1/RCK/p54, Pat1, Scd6/RAP55,
Edc3, the Lsm1-7 complex and the exonuclease Xrn1 (Parker and Sheth, 2007, Balagopal
and Parker, 2009). In agreement with previous observation that various cellular stresses
initiate the formation of P-bodies (Balagopal and Parker, 2009), we detected the change in
the expression level of P-bodies components in sciatic nerve after crush injury using
immunoblot analyses.
In particular, we made an interesting observation that sciatic nerve injury led to elevated
levels of GWB IC-6 and Dcp1 but decreased expression of Dcp2. The apparent discrepancy
may be partially explained by recent report in which, in vitro depletion of the decapping
enzyme Dcp2 caused increased P-bodies assembly (Franks and Lykke-Andersen, 2008).
While Dcp1 and Dcp2 are both core components of P-bodies, which catalyze removal of the
5′ cap structure from mRNA, they are structurally and functionally different. Dcp1 behaves
as a decapping enzyme regulatory subunit, while Dcp2 functions as a catalytic subunit of the
decapping enzyme (Sheth and Parker, 2003, She et al., 2008). Therefore, decreased level of
Dcp2 may results in accumulation of undigested mRNAs and thus in additional P-bodies
assembly. At the same time, another recent observation points out that mammalian cells
possess multiple mRNA decapping enzymes and Dcp2 protein may only modestly
contribute to bulk mRNA decay in mouse and human tissues (Song et al., 2010).
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We also observed an increase in the number and the size of P-bodies after conditioning
nerve lesion in the regenerating DRG axons. It is well known that conditioning sciatic nerve
crush produces robust regenerative response with concomitant increase in mRNA and
protein synthesis (Willis and Twiss, 2006). We presume that the increase in the pool of
mRNAs my initiate P-bodies assembly. Indeed, overexpression of a nontranslating mRNAs
in yeast (Teixeira et al., 2005) was shown to potentiate P-bodies formation. Moreover, the
size and number of P-bodies were proportional to the pool of untranslated mRNAs (Teixeira
et al., 2005, Parker and Sheth, 2007). Therefore, when mRNAs are trapped in association
with ribosomes, P-bodies decline; conversely, when mRNAs dissociate from ribosomes due
to inhibition of translation initiation, P-bodies increase in size and numbers (Teixeira et al.,
2005, Parker and Sheth, 2007, Balagopal and Parker, 2009). Consequently, nerve crush may
lead to a larger pool of untranslated mRNAs and to increase in the number and size of
functional P-bodies (Kedersha et al., 2005, Koritzinsky et al., 2006).
We made another interesting observation that P-bodies were preferentially localized to the
axon VR. The number of VR was markedly higher in the regenerating versus naïve DRG
axons. While the physiological role of VR is not clear their alleged function has been
associated with presynaptic terminals, places of action potential waveform modulation and
organelle accumulation and sequestration (Bennett and Muschol, 2009). In addition VR
were described as the sites of mRNA concentration and protein synthesis (Lee and
Hollenbeck, 2003). Interestingly, it was recently suggested that VR are the sites of clustering
of excess growth resources along developing neuritis (Malkinson and Spira, 2010). Our data
are complimentary to these observations suggesting that P-body machinery localized to VR
can regulate the growth resources by managing mRNAs pool.
Identification of miRNAs specifically expressed in injured sciatic nerve
We used microarrays and RT-PCR to profile miRNA expression changes in the sciatic nerve
of mice after injury. The results revealed a group of miRNAs expressed in an injury-
regulated pattern. For analysis, we chose three most highly upregulated miRNAs miR-21,
miR-142-5p, and miR-221, as well as brain-specific miR-124a, which was significantly
downregulated after nerve crush. Interestingly, miRNAs miR-21 and miR-142-5p were
reported to be also upregulated following brain injury (Lei et al., 2009). In addition,
miR-221 was found to be relatively abundant in distal axons of SCG and had elevated
expression level after spinal cord injury (Liu et al., 2009, Natera-Naranjo et al., 2010). The
brain-enriched miRNA miR-124 is an important regulator of the temporal progression of
adult neurogenesis in mice (Cheng et al., 2009b). Knockdown of endogenous miR-124
maintained subventricular zone stem cells as dividing precursors, whereas ectopic
expression led to increased neuron formation. Furthermore, blocking miR-124 function
during regeneration led to hyperplasias, followed by a delayed burst of neurogenesis (Cheng
et al., 2009a). Although the changes in the miRNA expression profile following injury and
development have been reported, the mechanism that regulates miRNA expression has not
been yet elucidated. In the current paper we revealed that expression of several miRNA
biosynthetic enzymes were injury-regulated. This let us to propose that the change in levels
of miRNA biosynthetic proteins may play a role in the injury-regulated expression of
miRNAs.
Taken together, our data implicate miRNA biosynthetic pathway in PNS response to injury.
Further studies should provide important insight into the role of specific miRNAs in
peripheral nerve regeneration. This finding may have significant clinical potential in the
treatment of neurodegenerative diseases, specifically those involving peripheral nerves.
Studies show that minimal RISC, basically an Argonaute 2 protein and a single-strand RNA,
is sufficient to catalyze target RNA recognition and cleavage (Yang and Yuan, 2009). Ago2
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and FMRP are both localized to the stress granules (SGs) where RNA integrated stress
response are proposed to occur.
Although no previous study has directly associated P-bodies with peripheral nerve health,
identification of patients with auto-immunity to GWBs suggests such a role. Clinical studies
indicate that these patients most often suffer from motor and sensory peripheral neuropathy
(Bhanji et al., 2007). Although it is not known whether the resulting neuropathy is axonal or
glial in its origin, it is logical to presume that autoimmune decrease of P-bodies in axon may
negatively impact intra-axonal translation and become detrimental to axon physiology.
CONCLUSIONS
Taken together, this work offers insights into the functional interplay between miRNAs and
their biosynthetic enzymes in peripheral nerve injury. In conclusion, we show that injury to
peripheral axons induces changes in the content and distribution of some biosynthetic
proteins of the miRNA machinery in cultured DRG neurons and their axons. Together with
previous findings, these observations suggest that, in addition to RISC, other factors such as
P-bodies might underlie the changes in regenerating axons induced by injury. Those factors
probably act in a synergistic way thus leading to the promoting regenerative axon growth.
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• MiRNAs and miRNA biosynthetic enzymes are injury-regulated in sciatic
nerve.
• Conditioning nerve lesion increases the number of P-bodies in axon varicosities.
• MiRNA pathway may play a regulatory role in the regenerative axon growth.
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Immunoblot analyses for FMRP, Ago2, and p-100 protein in sciatic nerve.
Proteins were extracted from 3 groups of pooled samples (intact sciatic nerves, the
contralateral naive nerve and the injured sciatic nerve) at 4 days or 7 days after a
conditioning nerve lesion. Immunoblot analyses were conducted with primary antibodies
against FMRP, AGO2, and p-100. Using the expression level in intact nerve as a control,
relative densitometric intensities were normalized to alpha-tubulin. Densitrometry showed a
more abundant expression of RISC component (FMRP, Ago2, p-100) in injured sciatic
nerve at both 4 days (A) and 7 days (B) after injury (N=3, * indicate P<0.05, ** indicate
P<0.01). Representative immunoblot of FMRP, Ago2, and p-100 protein is shown in C.
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Western Blot analyses of P-body components in the sciatic nerve after injury.
Western Blot analysis of P-body components in the sciatic nerve utilized the primary
antibody against Dcp1, Dcp2, Rap55, Ro52, and GWB IC6. Pooled samples (6 nerves per
each sample) were extracted from intact sciatic nerves, the contralateral naive nerve and the
injured sciatic nerve at 4 days or 7 days after a conditioning nerve lesion. Protein levels were
quantified by band densitomery and normalized to alpha-tubulin at 4 days (A) and 7 days
(B) after conditional lesion. Immunostaining for Dcp1, the catalytic factor of Dcp2, showed
an increase in expression in response to injury, whereas the expression of Dcp2, the
decapping enzyme, decreased after injury at both time points. Immunostaining for GWB
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IC-6 showed much higher GWB IC-6 expression at 4 days and 7 days after injury, while
Rap-55 showed no change in expression in response to injury. Ro52 expression level was
significantly decreased following injury (N=3, * indicates P<0.05, ** indicates P<0.01).
Representative immunoblots for Dcp1, Dcp2, Rap55, Ro52, and GWB IC6 are shown in C.
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Colocalization of P-body proteins in the VR of regenerating DRG axons.
Dissociated cultures of mouse DRG neurons collected 5 days after a conditioning lesion
were co-labeled with FITC (Green) conjugated antibodies to Dcp1 (B) and Alexia 594 (Red)
conjugated antibodies to GWB IC-6 (C). TUJ1 (Blue) staining is used to visualize the axon
(A). The merged images revealed co-localizations of investigated proteins in regenerating
axons (D). The Z-scanning further confirmed their overlapping expression in the VR (E).
White arrows in image D point at P-bodies in the VR.
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Number of VR containing P-bodies along the axon markedly increases after conditioning
lesion.
Low density dissociated DRG cultures were labeled with antibodies to neuronal marker
TUJ1 (Blue), Dcp1 (Green) and GWB IC-6 (Red). Merges of the images revealed the
localization of the P-bodies in soma and axon. The appearance of P-bodies was limited to
the VR along the axon. The fluorescent images in the upper panel show neuronal cultures
after sciatic conditioning lesion (A). The images in the lower panel show neurons from naïve
side (B). After lesion, the average number of VR containing P-bodies (white arrows) per
neuron has significantly increased (C). Scale bar on microphotographs is 100μm.
Wu et al. Page 19














Real-time qPCR for miRNAs. Graph indicates relative change in miRNA level. Total RNA
was isolated from intact and crushed sciatic nerves (n=6). Relative quantitation of miRNA
level was calculated against the reference gene (S12), and a relative fold change was
determined using the 2 ΔΔCT method (n=3, *p<0.05). The levels of miR-221, miR-142-5p
and miR-21 showed significant increase in sciatic nerve after crush.
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Colocalization of miRNAs and GWB in neurons and axons.
Fluorescent in-situ hybridization for miR-21 (A), miR-142-5p (B) revealed the distribution
of miRNAs in axon. Immunostaining for neuronal β-tubulin served as a neuronal marker and
immunostaining for GWB protein marked the localization of P-bodies. U6, a small nuclear
RNA was used as a positive control (C). Scrambled probes were used as another negative
control. . Green fluorescence shows the distribution of miRNAs and U6. Red fluorescence
indicates immunodetection of neuronal β-tubulin protein with TUJ1 antibodies (1:100). Blue
signals indicate GWB protein. White arrows indicate fluorescent signals within the axons
where miRNA and P-bodies components resided. Arrows with tail indicate neuronal cell
bodies, small arrows show P-bodies, arrow heads indicates the non-neuronal cells (Scale
bar=75μm).
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